Our Leadership
In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the R&D ecosystem.
In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining, and creating processes to make the drug development environment efficient, safe, and innovative.
Leadership
-
Karin Kramer Nielsen
Oversight Committee Chair, TransCelerate
Corporate Vice President Data Management, Novo Nordisk -
Andrew Hudson
Pharmacovigilance Steering Committee Chair, TransCelerate
Global Head, PV & Scientific Development, Roche -
Andy Lee
Corporate Treasurer, TransCelerate
SVP, Head of Global Clinical Trial Operations, Merck -
Robert Baker
Corporate Secretary, TransCelerate
VP, Clinical Program Design and Exploratory Medicine/Pharmacology, Eli Lilly and Company -
Janice Chang
COO, TransCelerate BioPharma Inc.
-
Jennifer Burgess
Vice President, Global Engagement & Communications, TransCelerate BioPharma Inc.
-
Rob DiCicco
Vice President, Portfolio Management, TransCelerate BioPharma, Inc.
-
Tony Garges
Head of Finance & Administration,
TransCelerate BioPharma Inc. -
Cara Rinaldi
Executive Director, Portfolio Management Lead, TransCelerate BioPharma Inc.
-
Jeneen Donadeo
Senior Director, Portfolio Management,
TransCelerate BioPharma Inc.
Board Of Directors
-
Dalvir Gill
CEO, TransCelerate BioPharma Inc.
-
Kate Owen
Chair of the Board, TransCelerate BioPharma; Head of Global Clinical Development Operations, Bristol Myers Squibb
-
Badhri Srinivasan
Vice-Chair of the Board, TransCelerate BioPharma; Head, Global Development Operations, Novartis
-
Eliav Barr
Senior Vice President, Global Clinical Development, Chief Medical Officer, MSD
-
Dietmar Berger
Chief Medical Officer, Global Head of Development, Sanofi
-
Uli Broedl
Corporate Senior Vice President and Head of Global Clinical Development & Operations at Boehringer Ingelheim
-
Christopher Corsico
SVP, Head of Development, GSK
-
Martin Holst Lange
Executive Vice President, Development, Novo Nordisk A/S
-
Neil Gallagher
Head of Development & CMO, AbbVie
-
Christoph Koenen
Head of Global Development and Clinical Operations, Pharmaceuticals Research & Development, Bayer
-
Maria Koutsopoulou
Senior Vice President, Head of Global Development Operations, Merck KGaA
-
Rob Lenz
Senior Vice President, Global Development, Amgen
-
Iris Loew-Friedrich
EVP and CMO, UCB
-
Cristian Massacesi
Chief Medical Officer and Chief Development Officer Oncology, AstraZeneca
-
Robert Metcalf
Senior Vice President, CDDA, China & Japan Medical, Eli Lilly and Company
-
William Pao
Chief Development Officer and Executive Vice President, Pfizer
-
Michelle Rohrer
SVP, Global Head of Pharma Regulatory and Policy, Roche
-
Peter Ronco
Head, Global Development, Janssen R&D
-
Takuko Sawada
Director, EVP, Shionogi & Co., Ltd.
-
Bernhardt Zeiher
Chief Medical Officer and President, Development, Astellas Pharma